BridgeMD
Comparison of Two Pain and Bleeding Control Methods in Back Surgery: A Study on Periarticular Vasoconstrictor Infiltration (PIV) vs. Erector Spinae Plane Block (ESP) in Lumbar Fusion Surgery.
EU CTIS ID: 2025-521572-56-00
What this study is testing
To compare the effectiveness of PIV block versus ESP block in reducing bleeding and improving postoperative pain control in lumbar fusion surgery, a procedure associated with significant blood loss and severe postoperative pain.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Men and women scheduled for lumbar fusion surgery (maximum of 3 instrumented levels).
- Age >18 years.
- Signed informed consent form
You likely can't join if
- Allergy to local anesthetics.
- Revision lumbar spine surgery.
- Patients with a local infection.
- Patients with connective tissue diseases or vasculitis.
- Chronic pain treated with opioids (Oral Morphine Equivalent Dose > 50 mg/day).
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.